Agent for preventing and/or treating vascular diseases

A pharmaceutical composition, which comprises 1) a COX-1 selective inhibitor or a pharmaceutically acceptable salt thereof and 2) clopidogrel or a pharmaceutically acceptable salt thereof.

A pharmaceutical composition for preventing and/or treating vascular diseases, which comprises 1) a COX-1 selective inhibitor or a pharmaceutically acceptable salt thereof and 2) clopidogrel or a pharmaceutically acceptable salt thereof.

Use of a COX-1 selective inhibitor or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for preventing and/or treating vascular diseases in combination with clopidogrel or a pharmaceutically acceptable salt thereof.

A method for preventing and/or treating vascular diseases, which comprises administering 1) an effective amount of clopidogrel or a pharmaceutically acceptable salt thereof and 2) an effective amount of a COX-1 selective inhibitor or a pharmaceutically acceptable salt thereof to the aforementioned human or animal.

A pharmaceutical composition for preventing and/or treating vascular diseases, which comprises 1) a formulation comprising a COX-1 selective inhibitor or a pharmaceutically acceptable salt thereof as an active ingredient and 2) a package insert indicating that said formulation is used in combination with a formulation containing clopidogrel or a pharmaceutically acceptable salt thereof as an active ingredient.